Organic dyes incorporating the oxadiazole moiety for efficient dye-sensitized solar cells
US-2016343515-A1 · Nov 24, 2016 · US
Pain-relieving compositions and uses therefor
US9994534B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9994534-B2 |
| Application number | US-201715669834-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 4, 2017 |
| Priority date | Dec 29, 2006 |
| Publication date | Jun 12, 2018 |
| Grant date | Jun 12, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compositions and methods are for inducing, promoting or otherwise facilitating pain relief. More particularly, sub-normovasodilatory doses of nitric oxide donors are used in the therapeutic management of vertebrate animals including humans, for the prevention or alleviation of pain, especially neuropathic pain. In some applications of the method, nitric oxide donors can be administered by any suitable route so as to provide concentrations of NO that are about ½ to 10 −15 times those known to induce vasodilation in normal circulations.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I): wherein one of R 1 and R 2 is selected from C 1-3 alkyl; and the other of R 1 and R 2 is selected from C 1 alkylphenyl substituted with hydroxyl; ethyl substituted with hydroxyl; and —CH 2 N(ethyl) 2 . 2. The compound according to claim 1 wherein one of R 1 and R 2 is methyl. 3. The compound according to claim 1 wherein one of R 1 and R 2 is methyl and the other is C 1 alkylphenyl substituted with hydroxyl. 4. The compound according to claim 3 wherein the hydroxyl is substituted on the alkyl group. 5. The compound according to claim 1 wherein one of R 1 and R 2 is methyl and the other is ethyl substituted with hydroxyl. 6. The compound according to claim 1 wherein one of R 1 and R 2 is methyl and the other is —CH 2 N(ethyl) 2 .
Assignees
Inventors
Classifications
Medicinal preparations containing organic active ingredients · CPC title
Oxadiazoles · CPC title
- C07D271/08Primary
1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles · CPC title
Esters, e.g. nitroglycerine, selenocyanates · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9994534B2 cover?
- Compositions and methods are for inducing, promoting or otherwise facilitating pain relief. More particularly, sub-normovasodilatory doses of nitric oxide donors are used in the therapeutic management of vertebrate animals including humans, for the prevention or alleviation of pain, especially neuropathic pain. In some applications of the method, nitric oxide donors can be administered by any s…
- Who is the assignee on this patent?
- Univ Queensland
- What technology area does this patent fall under?
- Primary CPC classification C07D271/08. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).